Angiogenesis and Tissue Repair Depend on Platelet Dosing and Bioformulation Strategies Following Orthobiological Platelet-Rich Plasma Procedures. A Narrative Review
Preprint
- 12 June 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Angiogenesis is new blood vessel formation from existing vessels and is a critical first step in tissue repair following chronic disturbances in healing and degenerative tissues. Chronic pathoanatomic tissues are characterized by a high number of inflammatory cells, overexpression of inflammatory mediators, such as tumor necrosis factor-α (TNF-α) and interleukin-1 (IL-1), the presence of mast cells, T cells, reactive oxygen species, and matrix metalloproteinases, and a decreased angiogenic capacity. Multiple studies have demonstrated that autologous orthobiological cellular preparations (e.g., platelet-rich plasma [PRP]) im-prove tissue repair and regenerate tissues. There are many PRP devices on the market. Unfortunately, they differ greatly in platelet numbers, cellular composition, and bioformulation. PRP is a platelet concentrate consisting of a high concentration of platelets with or without certain leukocytes, platelet-derived growth factors (PGFs), cytokines, molecules, and signaling cells. Several PRP products have immunomodulatory capacities that can influence resident cells in a diseased microenvironment, inducing tissue repair or re-generation. Generally, PRP is a blood-derived product, regardless of its platelet number and bioformulation, and the literature indicates both positive and negative patient treatment outcomes. Strangely, the literature does not designate specific PRP preparation qualifications that can potentially contribute to tissue re-pair. Moreover, the literature scarcely addresses the impact of platelets and leukocytes in PRP on (neo)angiogenesis other than a general one-size-fits-all statement that “PRP has angiogenic capabilities.” Here, we review the cellular composition of all PRP constituents, including leukocytes, and describe the importance of platelet dosing and bioformulation strategies in orthobiological applications to initiate angiogenic pathways that re-establish microvasculature networks, facilitating the supply of oxygen and nutrients to impaired tissues.Keywords
All Related Versions
- Version 1, 2023-06-12, Preprints
- Published version: Biomedicines, 11 (7), 1922.
This publication has 189 references indexed in Scilit:
- Clinical outcomes following intradiscal injections of higher-concentration platelet-rich plasma in patients with chronic lumbar discogenic painInternational Orthopaedics, 2022
- Effect of Platelet-Rich Plasma Injection vs Sham Injection on Tendon Dysfunction in Patients With Chronic Midportion Achilles TendinopathyJAMA, 2021
- Neutrophils in tissue injury and repairCell and tissue research, 2018
- Platelet-rich plasma in tendon-related disorders: results and indicationsKnee Surgery, Sports Traumatology, Arthroscopy, 2016
- Evaluation of the tibial tunnel after intraoperatively administered platelet‐rich plasma gel during anterior cruciate ligament reconstruction using diffusion weighted and dynamic contrast‐enhanced MRIJournal of Magnetic Resonance Imaging, 2012
- Normal ranges of angiogenesis regulatory proteins in human plateletsAmerican Journal of Hematology, 2010
- Antimicrobial activity of platelet‐leukocyte gel against Staphylococcus aureusJournal of Orthopaedic Research, 2007
- Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applicationsJournal of Cellular Physiology, 2005
- Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrixMicroscopy Research and Technique, 2002
- Human neutrophils secrete vascular endothelial growth factorJournal of Leukocyte Biology, 1997